1 hr ago | Applied Clinical Trials
Oramed Pharmaceuticals Inc. , a developer of oral drug delivery systems, announced today that the United States Food and Drug Administration has cleared the Company's Investigational New Drug application for ORMD-0801, its oral insulin capsule.
5 hrs ago | The Motley Fool
Keep track of the stocks that matter to you. Help yourself with the Fool's FREE and easy new watchlist service today.
9 hrs ago | KSL-TV
A West Jordan man charged with selling a Viagra-like drug as a natural supplement has pleaded guilty to charges in two separate federal indictments.
13 hrs ago | Times of Oman
A logo of Swiss pharmaceutical company Roche is pictured at a company's building in Rotkreuz, April 12, 2012.
13 hrs ago | NutraIngredients-USA
Whether the food industry likes it or not, when it comes to GMO labeling, the " train appears to have left the station", according to former FDA associate commissioner of foods Dr David Acheson.
15 hrs ago | WJRT
FRIDAY, May 10 -- New labeling laws for sunscreen will help American consumers choose the product that provides the best sun protection, experts say.
19 hrs ago | Philly.com
The recent controversy surrounding the morning-after contraceptive pill called Plan B One-Step has been argued in political, regulatory, and legal circles.
Ranbaxy, an India-based generic drug manufacturer, has pleaded guilty to federal drug safety violations and has agreed to pay $500 million in fines to resolve claims that it sold substandard drugs, The New York Times reports.
The Food and Drug Administration approved the use of Janssen Biotech's Simponi for the treatment of moderately-to-severely active ulcerative colitis in adult patients who have demonstrated corticosteroid dependence or did not respond to other therapies.
An experimental drug that taps the power of the body's immune system to fight cancer is shrinking tumors in patients for whom other treatments have failed, an early study shows.
A fear that carrot and beet juice from a US company could be contaminated with Clostridium botulinum has prompted the US Food and Drug Administration to warn consumers about the potential health risks.
On May 13, 2013, generic drug manufacturer Ranbaxy USA Inc. , a subsidiary of Indian generic drug manufacturer Ranbaxy Laboratories Limited, pled guilty to seven felony charges as part of a global settlement pursuant to which Ranbaxy will pay a total of $500 million to resolve criminal and civil False Claims Act liability.
Today the US Food and Drug Administration is announcing that it has approved Xofigo to treat men with symptomatic late-stage, castration-resistant prostate cancer that has spread to bones but not to other organs.
A prostate cancer drug developed by a biotech that's relatively new on the Cambridge, Mass.
Dear Abby: When friends and family get together, the conversation often turns to the subject of health.
FDA has released guidance on best practices for conducting and reporting pharmacoepidemiologic safety studies, specifically studies that use electronic healthcare data including administrative claims data and electronic medical record data.